<?xml version="1.0" encoding="UTF-8"?>
<p>A randomized, double‐blind, placebo‐controlled, escalating single‐dose study with Rolontis was conducted in 40 healthy Korean subjects. Doses of Rolontis ranged from 5 to 350 
 <italic>μ</italic>g/kg. Rolontis showed dose‐dependent pharmacokinetic properties, and the area under the effect‐time curve (AUEC
 <sub>last</sub>) of both the absolute neutrophil count (ANC) and the CD34
 <sup>+</sup> cell count increased as the dose increased 
 <xref rid="cam41388-bib-0012" ref-type="ref">12</xref>.
</p>
